Skip to main content
OpenTrials

Clinical trial condition

Subcutaneous Emphysema

Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.

97 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Subcutaneous Emphysema trial results

Active, Not Recruiting

Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants

NCT06738017

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of California, San Diego San Diego, California, United States
  • Saint Louis University St Louis, Missouri, United States
  • Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States
  • The Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Active, Not Recruiting

Alpha-1 Antitrypsin Deficiency Adult Liver Study

NCT02014415

Conditions
Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +10 more
Locations
  • University of California San Diego, California, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Saint Louis University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD

NCT06405633

Conditions
Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • St. Vincent's Hospital, Melbourne Fitzroy, Victoria, Australia
  • Dalhousie University - Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
  • Inspiration Research Limited Toronto, Ontario, Canada
  • Turku University Hospital Turku, Finland
View Trial Details
Active, Not Recruiting

Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema

NCT05897424

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • UAB Lung Health Center- Site Number : 105 Birmingham, Alabama, United States
  • St Joseph's Hospital and Medical Center- Site Number : 126 Phoenix, Arizona, United States
  • David Geffen School of Medicine at UCLA- Site Number : 124 Los Angeles, California, United States
  • University of California Davis Medical Center- Site Number : 110 Sacramento, California, United States
View all 40 locations
View Trial Details
Active, Not Recruiting

Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease

NCT05297812

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • National Jewish Health Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

NCT05899673

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • UCSD Altman Clinical and Translational Research Institute La Jolla, California, United States
  • Stanford Medicine Outpatient Center Redwood City, California, United States
  • UF Clinical and Translational Science Institute Gainesville, Florida, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
View Trial Details

Related conditions